cervic
cancer
second
common
cancer
among
women
china
chen
et
al
almost
case
result
persist
infect
human
papillomaviru
hpv
bosch
et
al
hpv
larg
viral
famili
consist
differ
type
bernard
et
al
among
type
high
oncogen
properti
regard
highrisk
type
highrisk
type
hpv
rel
low
selfclear
rate
compar
lowrisk
type
hpv
safaeian
et
al
prevent
infect
highrisk
hpv
occurr
cervic
cancer
sever
prophylact
vaccin
like
cervarix
gardasil
gardasil
deschuyten
et
al
mccormack
develop
approv
market
mani
countri
howev
therapeut
vaccin
drug
approv
clinic
use
treat
hpvinfect
patient
hpv
nonenvelop
doublestrand
dna
viru
capsid
made
two
protein
major
protein
minor
protein
involv
receptor
bind
viral
entri
analysi
atom
structur
nativ
hpv
viruslik
particl
vlp
reveal
pentam
form
icosahedr
shell
hpv
baker
et
al
li
et
al
pentam
strongli
bind
hpv
receptor
heparan
sulfat
proteoglycan
hspg
basement
membran
mediat
viral
entri
infect
kine
et
al
highli
potent
neutral
antibodi
elicit
hpv
vaccin
found
bind
protein
prevent
hpv
infect
li
et
al
thu
pentam
regard
import
target
develop
antivir
agent
hpv
infect
viral
entri
inhibitor
repres
class
antivir
agent
inhibit
viru
infect
block
viru
entri
host
cell
jiang
et
al
report
first
peptidebas
hiv
entri
inhibitor
jiang
et
al
first
hiv
entri
inhibitorbas
antihiv
drug
enfuvirtid
approv
us
fda
clinic
use
dando
perri
later
jiang
colleagu
report
anhydridemodifi
protein
anhydrid
modifi
protein
potent
viru
entri
inhibitor
number
envelop
virus
hiv
neurath
et
al
herp
simplex
viru
hsv
neurath
et
al
ebola
viru
ebov
li
et
al
jiang
group
report
bovin
betalactoglobulin
could
also
inhibit
entri
target
cell
pseudoviru
psv
nonenvelop
viru
hpv
highrisk
lowrisk
lu
et
al
clinic
trial
topic
applic
vagin
gel
contain
proven
safe
highli
effect
suppress
hpv
infect
reduc
viral
load
vagin
mucosa
guo
et
al
b
howev
still
understand
molecular
mechan
inhibit
hpv
infect
studi
found
could
inactiv
hpv
psv
effect
inhibit
hpv
psv
entri
host
cell
via
interact
viru
cell
unlik
could
bind
protein
peptid
deriv
posit
charg
region
hpv
protein
suggest
inhibit
hpv
infect
bind
via
neg
charg
region
protein
thu
competit
block
hpv
bind
receptor
basement
membran
vagin
mucosa
inhibit
hpv
enter
replic
host
cell
also
shown
topic
appli
enter
host
cell
blood
circul
therefor
formul
safe
use
vagina
treatment
hpv
infect
prevent
cervic
cancer
develop
anhydrid
hp
acid
tnb
human
serum
albumin
hsa
chicken
ovalbumin
ova
bovin
serum
albumin
bsa
purchas
sigma
horseradish
peroxidas
hrp
conjug
goat
antihuman
iga
ige
antibodi
purchas
abcam
uk
hrpconjug
rabbit
antimous
igg
antibodi
purchas
dako
denmark
plasmid
luciferas
pclucf
plasmid
kindli
provid
dr
john
schiller
laboratori
cellular
oncolog
nation
cancer
institut
nih
md
usa
anhydridemodifi
protein
produc
previous
describ
lu
et
al
briefli
kind
protein
dissolv
phosphat
buffer
ph
final
concentr
mgml
afterward
protein
solut
mix
anhydrid
hp
dmso
final
concentr
mm
addit
five
equal
aliquot
interv
ph
adjust
naoh
mix
mixtur
kept
two
hour
dialyz
pb
hpv
pseudoviru
produc
previous
briefli
cell
seed
cultur
dish
cell
h
transfect
transfect
mixtur
plasmid
pclucf
plasmid
psv
mixtur
plasmid
pclucf
plasmid
psv
use
vigofect
vigor
biotechnolog
corp
cell
suspend
ml
lysi
buffer
incub
h
slow
rotat
lysat
cool
ice
min
mix
nacl
solut
adjust
concentr
nacl
kept
ice
min
lysat
centrifug
g
min
quantifi
concentr
capsid
protein
level
remov
aggreg
pseudovirion
stock
filter
use
neutral
assay
inhibitori
activ
hpv
psv
entri
hela
hacat
cell
detect
previous
describ
surviladz
et
al
kwak
et
al
briefli
hela
heccatt
cell
seed
cell
fb
dmem
per
well
plate
follow
cultur
overnight
serial
dilut
dmem
incub
hpv
psv
equal
ng
mixtur
ad
hela
hacat
cell
incub
h
replac
cultur
supernat
free
medium
cultur
addit
h
cell
lyse
measur
luciferas
activ
accord
manufactur
manual
promega
madison
wi
usa
dilut
pb
coat
onto
well
polystyren
plate
corn
usa
overnight
block
proteinfre
block
buffer
thermo
fisher
scientif
usa
hpv
protein
ad
well
plate
incub
h
wash
pbst
three
time
mous
antihpv
antibodi
abcam
uk
ad
dilut
incub
h
wash
hrpconjug
rabbit
antimous
igg
antibodi
dako
denmark
ad
h
wash
ad
tetramethylbenzidin
sigma
usa
absorb
measur
nm
similar
protocol
use
detect
serum
rhesu
monkey
iga
ige
vagin
swab
eluat
leftov
sampl
clinic
trial
evalu
vivo
safeti
efficaci
intravagin
appli
vagin
gel
registri
guo
et
al
b
two
posit
charg
peptid
hpv
protein
residu
lkakpkftlgkrkat
residu
ststtakrkkrkl
synthes
standard
solidphas
fmoc
method
previous
report
et
al
peptid
solut
mm
prepar
mm
phosphat
buffer
ph
ad
titrat
sampl
cell
also
dissolv
phosphat
buffer
ad
titrat
needl
isotherm
titrat
calorimetri
itc
analysi
carri
constant
temperatur
stir
speed
revmin
titrat
volum
titrat
interv
first
drop
other
hela
cell
plate
plate
overnight
cell
incub
final
concentr
h
h
addit
hpv
psv
equal
ng
follow
incub
h
replac
cultur
supernat
fresh
medium
incub
addit
h
cell
lyse
determin
entri
inhibit
ratio
accord
manufactur
manual
promega
hela
cell
plate
preincub
h
wash
dmem
three
time
addit
hpv
psv
control
hela
cell
wash
hpv
psv
ad
hpv
psv
entri
hela
cell
detect
describ
plate
hela
cell
mixtur
prechil
min
cell
incub
mixtur
h
wash
cold
pb
buffer
twice
cell
incub
h
cell
lyse
determin
luciferas
activ
accord
luciferas
assay
system
manual
promega
usa
experi
rhesu
macaqu
conduct
ethic
guidelin
approv
ethic
committe
institut
laboratori
anim
scienc
chines
academi
medic
scienc
peke
union
medic
colleg
approv
number
brief
rhesu
macaqu
randomli
divid
treatment
group
control
group
treatment
group
vagin
gel
contain
mg
per
dose
dispers
carbom
gel
administ
intravagin
rectal
control
group
carbom
gel
appli
ml
blood
collect
inject
h
h
min
h
h
h
h
h
h
serum
separ
condens
determin
whether
could
enter
hela
cell
cell
seed
onto
coverslip
plate
ad
h
supernat
replac
dmem
contain
fb
day
cell
fix
paraformaldehyd
pfa
sigmaaldrich
st
loui
mo
perfor
triton
block
bsa
amresco
llc
solon
oh
next
cell
incub
overnight
mab
mab
five
wash
cell
incub
alexa
fluor
donkey
antimous
igg
thermo
fisher
scientif
wilmington
de
usa
room
temperatur
five
wash
coverslip
seal
prolong
gold
antifad
reagent
thermo
fisher
scientif
scan
leica
confoc
microscop
previou
studi
shown
anhydridemodifi
bovin
betalactoglobulin
promis
hpv
entri
inhibitor
entri
psv
highrisk
lowrisk
hpv
type
lu
et
al
inhibitori
activ
attribut
interact
increas
net
neg
charg
anhydrid
modif
lu
et
al
one
may
ask
whether
protein
increas
net
neg
charg
inhibit
hpv
entri
target
cell
answer
question
compar
inhibitori
activ
anhydridemodifi
human
serum
albumin
anhydridemodifi
chicken
ovalbumin
entri
psv
hela
cell
use
unmodifi
hsa
ova
control
shown
figur
exhibit
potent
antihpv
activ
dosedepend
manner
half
maxim
inhibitori
concentr
potent
three
unmodifi
protein
concentr
high
show
signific
inhibitori
activ
psv
entri
target
cell
result
confirm
protein
hsa
modifi
anhydrid
gain
abil
inhibit
hpv
infect
previou
studi
prove
antivir
activ
entri
highrisk
hpv
type
lowrisk
hpv
type
target
cell
lu
et
al
asid
three
repres
hpv
type
worldwid
anoth
import
highrisk
type
found
high
incid
china
determin
whether
also
effect
construct
pseudoviru
test
sensit
control
shown
figur
could
also
inhibit
psv
entri
target
cell
dosedepend
manner
confirm
broadspectrum
antihpv
activ
consid
hacat
cell
express
abund
integrin
heparan
sulfat
proteoglycan
hspg
receptor
hpv
aksoy
et
al
kumar
et
al
act
target
cell
hpv
infect
also
evalu
inhibitori
activ
psv
entri
hacat
cell
shown
figur
also
effect
entri
psv
hacat
cell
suggest
act
viru
rather
target
cell
propos
inhibit
hpv
psv
entri
target
cell
possibl
bind
neg
charg
residu
posit
charg
residu
protein
surfac
viral
particl
therebi
block
interact
viral
protein
receptor
target
cell
lu
et
al
howev
still
unclear
protein
viru
surfac
may
involv
interact
abund
protein
hpv
particl
protein
detect
interact
hpv
protein
elisa
shown
figur
ab
could
strongli
bind
protein
unmodifi
protein
could
ctermin
posit
charg
region
hpv
prove
regul
bind
hpv
receptor
sibbet
et
al
bousarghin
et
al
region
expos
viral
surfac
involv
bind
cell
surfac
receptor
neutral
antibodi
therefor
synthes
two
posit
charg
peptid
region
protein
residu
residu
bind
abil
peptid
measur
isotherm
titrat
calorimetri
itc
shown
figur
obviou
bind
peptid
show
high
bind
abil
bind
constant
valu
equal
bind
constant
k
valu
equal
result
suggest
may
bind
posit
charg
site
ctermin
region
protein
hpv
surfac
block
interact
viral
particl
cell
receptor
determin
whether
could
inactiv
hpv
psv
incub
hpv
psv
room
temperatur
h
remov
precipit
shown
figur
treat
viru
could
still
infect
target
host
cell
reduc
activ
compar
control
viru
dmem
suggest
bind
hpv
psv
may
noncoval
revers
perman
inact
viru
hpv
entri
host
cell
take
h
rel
slow
process
compar
virus
aksoy
et
al
provid
long
window
period
entri
inhibitor
bind
viral
protein
respons
interact
receptor
target
cell
block
viral
entri
perform
timeaddit
assay
pinpoint
window
function
block
hpv
entri
target
cell
shown
figur
could
fulli
inhibit
psv
entri
ad
cell
h
h
addit
psv
respect
psv
entri
block
ad
cell
h
addit
psv
respect
figur
result
suggest
rel
long
period
entri
process
aksoy
et
al
entri
inhibitor
remain
suffici
activ
inhibit
hpv
psv
entri
target
cell
confirm
function
stage
block
viral
entri
use
temperatur
shift
assay
slow
viral
infect
process
hpv
psv
could
bind
cell
receptor
could
fulli
enter
cytoplasm
speed
membran
fusion
cytoskelet
transform
larg
reduc
low
temperatur
incub
hpv
psv
hela
cell
h
hpv
could
bind
cell
surfac
wash
away
unbound
hpv
shift
cell
h
incub
ad
cell
begin
remov
wash
viral
entri
occur
figur
prove
block
attach
psv
cell
receptor
earliest
stage
infect
determin
whether
could
also
bind
receptor
target
cell
surfac
block
hpv
entri
incub
hela
cell
control
h
cell
wash
dmem
remov
unbound
protein
wash
control
addit
hpv
psv
wash
condit
hpv
psv
entri
hela
cell
block
nonwash
condit
hpv
psv
entri
hela
cell
effect
block
inhibit
observ
control
group
matter
whether
hela
cell
wash
wash
figur
result
suggest
inhibit
hpv
psv
entri
hela
cell
result
bind
hpv
receptor
host
cell
determin
whether
intravagin
appli
could
enter
epitheli
cell
incub
hela
cell
cell
h
wash
cell
three
time
use
pb
cell
stain
mous
antibodi
antibodi
control
alexa
fluor
donkey
antimous
igg
differ
antibodytr
cell
show
strong
fluoresc
signal
antibodytr
cell
display
signific
fluoresc
signal
insid
outsid
cell
figur
result
indic
could
neither
enter
cell
bind
cell
surfac
protein
includ
receptor
hpv
investig
whether
topic
appli
enter
blood
circul
carbom
gel
without
topic
administ
vagina
anu
rhesu
macaqu
blood
sampl
collect
differ
time
point
gel
applic
concentr
blood
sampl
gel
posit
control
quantifi
elisa
use
mab
shown
figur
detect
blood
sampl
rhesu
macaqu
vagin
rectal
administ
carbom
gel
without
confirm
topic
appli
enter
blood
circul
acut
hpv
infect
becom
persist
lead
variou
form
cancer
shanmugasundaram
cervic
cancer
although
sever
multival
prophylact
hpv
vaccin
use
clinic
prevent
hpv
infect
cervic
cancer
develop
effect
preexist
hpv
infect
middleag
elderli
women
popul
high
risk
cervic
cancer
therefor
essenti
develop
effect
safe
therapeut
agent
treatment
hpv
infect
order
reduc
morbid
cervic
cancer
viral
entri
inhibitor
proven
effect
safe
treatment
viral
infect
jiang
et
al
dando
perri
lu
et
al
li
et
al
su
et
al
previous
report
hpv
entri
inhibitor
highli
effect
block
entri
hpv
high
lowrisk
type
host
cell
lu
et
al
random
clinic
trial
topic
applic
vagin
gel
contain
shown
excel
efficaci
safeti
treat
highrisk
hpv
infect
guo
et
al
b
howev
inhibit
hpv
entri
target
cell
still
unclear
previou
studi
demonstr
inhibitori
activ
hpv
psv
entri
target
cell
close
correl
number
posit
charg
lysin
arginin
residu
modifi
ie
net
neg
charg
lu
et
al
suggest
neg
charg
residu
play
import
role
inhibit
hpv
infect
shown
figur
unmodifi
bovin
contain
posit
charg
residu
ly
arg
neg
charg
residu
asp
glu
qin
et
al
thu
net
charg
ly
arg
modifi
mm
lu
et
al
result
neutral
posit
charg
therefor
net
charg
becom
make
activ
bind
viral
protein
high
posit
net
charg
inhibit
viru
infect
studi
demonstr
could
strongli
bind
protein
psv
unmodifi
protein
could
figur
use
itc
analysi
show
unlik
could
strongli
interact
posit
charg
residueenrich
ctermin
region
residu
protein
respons
attach
hpv
particl
host
cell
possibl
interact
cellular
receptor
one
may
argu
may
bind
viru
high
net
posit
charg
surfac
protein
inhibit
infect
inde
also
inhibit
infect
simian
immunodefici
viru
siv
wyand
et
al
hsv
neurath
et
al
effect
infect
merscov
vsv
unpublish
data
studi
show
hsa
also
effect
ova
effect
inhibit
hpv
psv
entri
figur
even
though
also
contain
high
net
neg
charg
surfac
thu
asid
high
net
neg
charg
result
suggest
activ
site
bind
viral
protein
must
possess
conform
fit
correspond
site
viral
protein
figur
enabl
strongli
close
interact
viral
protein
block
hpv
entri
host
cell
inde
molecular
dock
analysi
indic
could
strongli
bind
posit
charg
region
hpv
protein
bind
site
neg
charg
hspg
receptor
hpv
figur
mani
neg
charg
surfac
interfac
much
larger
hspg
molecul
therefor
competit
bind
hpv
block
bind
hspg
receptor
base
result
obtain
studi
propos
mechanist
model
inhibit
hpv
infect
cervic
mucosa
figur
newli
invad
hpv
access
basal
cell
layer
micro
lesion
break
cervic
epithelium
bind
hspg
receptor
basement
membran
interact
posit
charg
region
protein
hpv
neg
charg
region
hspg
interact
result
seri
conform
chang
capsid
lead
proteas
digest
exposur
n
terminu
thu
initi
entri
hpv
epitheli
cell
kine
et
al
pyeon
et
al
hpv
infect
epitheli
cell
gradual
matur
along
host
cell
cycl
move
toward
top
layer
epithelia
follow
eventu
releas
epiderm
cell
newli
releas
hpv
particl
access
basement
membran
micro
lesion
cervic
epithelium
start
anoth
infect
replic
cycl
gradual
establish
persist
infect
promot
develop
cervic
cancer
topic
appli
vagina
bind
protein
newli
invad
newli
releas
hpv
block
attach
hpv
basement
membran
therebi
inhibit
entri
hpv
host
cell
replic
treatment
certain
period
time
eg
month
newli
produc
hpvfree
epitheli
cell
lower
part
mucos
epithelium
expect
move
upward
push
hpvinfect
cell
away
vagin
mucosa
movement
acceler
menstrual
period
make
layer
mucos
epithelium
free
hpv
infect
consid
presenc
micro
lesion
break
cervic
epithelium
possibl
caus
sexual
activ
requir
hpv
access
hspg
receptor
basement
membran
bousarghin
et
al
combin
use
biocompat
materi
mucosa
wound
heal
human
collagen
protein
hua
et
al
may
synergist
complementari
effect
hpv
infect
result
timeofaddit
assay
cell
washout
assay
viru
inactiv
indic
could
interact
virion
rather
cell
effect
block
entri
hpv
psv
target
cell
could
inactiv
virion
figur
biolog
properti
make
ideal
antihpv
agent
topic
applic
treat
hpv
infect
interact
hpv
particl
vagin
mucosa
block
virion
bind
receptor
eg
hspg
basement
membran
sinc
enter
cell
blood
circul
expect
caus
system
toxic
human
induc
harm
antibodi
therefor
topic
formul
contain
safe
use
treat
local
hpv
infect
dataset
gener
studi
includ
manuscriptsupplementari
file
anim
studi
review
approv
institut
laboratori
anim
scienc
chines
academi
medic
scienc
peke
union
medic
colleg
approv
number
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
